Funding for this research was provided by:
U.S. Department of Defense (W81XWH-16-C-0142)
Received: 25 January 2022
Accepted: 4 July 2022
First Online: 16 July 2022
: The views expressed are solely those of the authors and do not reflect the official policy or position of the US Army, US Navy, US Air Force, the Department of Defense, or the US Government. Dr. Laskowitz is an officer and has equity in Aegis CN, LLC which supplied the study drug. Dr. Wang serves as a consultant for Aegis CN, LLC. Aegis CN, LLC had no editorial control over the study design, its execution, or the writing of this manuscript. Duke University has equity and an intellectual property stake in CN-105.
: All experiments were approved by and conducted in accordance with the Duke University Institutional Animal Care and Use Committee.
: Not applicable.